Prestige Consumer Healthcare
PBH
#4266
Rank
NZ$4.68 B
Marketcap
NZ$97.35
Share price
-0.54%
Change (1 day)
-27.78%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): NZ$6.53

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is NZ$6.48. In 2024 the company made an earnings per share (EPS) of NZ$7.32 an increase over its 2023 EPS that were of NZ-$2.74.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$6.53-10.72%
2024NZ$7.32-367.08%
2023NZ-$2.74-138.33%
2022NZ$7.1511.7%
2021NZ$6.4013.6%
2020NZ$5.63-651.67%
2019NZ-$1.02-148.78%
2018NZ$2.09-83.29%
2017NZ$12.52437.23%
2016NZ$2.33-34.13%
2015NZ$3.5452.94%
2014NZ$2.31-8.11%
2013NZ$2.52
2011NZ$1.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.95 192.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
NZ$11.76 81.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.25 88.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.31-64.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.38-1.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
NZ$10.46 61.42%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
NZ$2.40-62.99%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.41-1.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
NZ-$50.40-877.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$2.08-67.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel